In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis

Plasma fibrinogen, C-reactive protein (CRP), and interleukin-6 (IL-6) levels in patients with acute myocardial infarction (AMI) receiving thrombolysis have been related to prognosis. The aim of this study was to investigate the time course of plasma fibrinogen, CRP, and IL-6 levels during the in-hos...

Full description

Saved in:
Bibliographic Details
Published in:Angiology 2006-05, Vol.57 (3), p.283-293
Main Authors: Ziakas, A., Gavrilidis, S., Giannoglou, G., Souliou, E., Gemitzis, K., Kalampalika, D., Vayona, M. Arvanitidou, Pidonia, I., Parharidis, G., Louridas, G.
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Blood and lymphatic vessels
C-Reactive Protein - metabolism
Cardiology. Vascular system
Coronary heart disease
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Fibrinogen - metabolism
Fibrinolytic Agents - therapeutic use
Follow-Up Studies
Heart
Hospitalization
Humans
Interleukin-6 - blood
Male
Medical sciences
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - complications
Myocardial Infarction - drug therapy
Neurology
Prognosis
Streptokinase - therapeutic use
Thrombolytic Therapy
Tissue Plasminogen Activator - therapeutic use
Vascular diseases and vascular malformations of the nervous system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Plasma fibrinogen, C-reactive protein (CRP), and interleukin-6 (IL-6) levels in patients with acute myocardial infarction (AMI) receiving thrombolysis have been related to prognosis. The aim of this study was to investigate the time course of plasma fibrinogen, CRP, and IL-6 levels during the in-hospital phase in patients with AMI receiving thrombolysis, and their relationship to in-hospital and prognosis after 12-months follow-up. In 40 patients presenting with AMI within 6 hours of symptom onset and treated with thrombolysis, plasma fibrinogen, CRP, and IL-6 levels were measured on admission and after 6, 12, 24, 48, and 72 hours; 7 days; and 6 months. Patients with other diseases that can alter fibrinogen, CRP, or IL-6 levels were excluded. Patients had a clinical follow-up at 6 and 12 months, and the following cardiac events were recorded: cardiac death, recurrent angina, recurrent AMI, and heart failure. Plasma fibrinogen concentrations decreased significantly (p
ISSN:0003-3197
1940-1574
DOI:10.1177/000331970605700304